Culture

10/15/26

Costco Is a Model for Drug Middlemen, Not Drug Inventors

Biotech

Policy

Culture

10/08/26

Weight Loss? We’re Betting on a Future Where People Don’t Gain Weight in the First Place

Biotech

Science

Culture

Finance

10/07/26

Another Day in Paradox: Here’s how we got the public to not hate pharma quite as much

Biotech

Policy

Culture

06/01/26

RA Capital’s work in China: A personal viewpoint

Biotech

Culture

05/01/26

The infectious positivity of Mario Barro

Biotech

Science

Culture

04/10/26

I move for joy: Let’s reinvent biotech boards

Biotech

Culture

Finance

12/19/25

What you were reading — Rapport’s top stories of 2025

Biotech

Culture

Finance

Policy

Science

09/22/25

The CDC once rescued my faith in science — who will rescue us now?

Biotech

Culture

Policy

Science

09/15/25

Resolving the Massachusetts Paradox

Biotech

Culture

Policy

09/10/25

Getting personal with three investment leaders at RA Capital

Biotech

Culture

Finance

08/19/25

Capstan: The Story of the Open Minds Behind the Acquisition of an In Vivo CAR‑T Pioneer

Culture

Finance

Science

07/30/25

Can AI Get the Flu and Take My Job?

Culture

Finance

06/03/25

Eating the world

Culture

Planetary

06/03/25

Swamp gas rising

Culture

Planetary

06/03/25

The trouble with fertilizer

Culture

Planetary

05/27/25

Agriculture: Hiding in Plain Sight

Culture

Science

Planetary

02/15/25

A Vaccine for your Mind

Biotech

Culture

Science

02/13/25

2025 Pharma Superbowl Ads: Moving … but not moving the needle where it matters most

Biotech

Culture

02/04/25

Planetary Tech March Madness

Culture

Finance

Planetary

01/31/25

How to navigate and de-risk your next career move in biotech (2025)

Biotech

Culture